Ludwig M, Grimm T, Brackmann H H, Olek K
Institute of Experimental Haematology and Blood Transfusion, Bonn, Germany.
Am J Hum Genet. 1992 Jan;50(1):164-73.
Genomic amplification followed by direct sequencing enabled us to establish the causative mutation in 67 unrelated hemophilia B patients of predominantly German origin. With the detection of the mutation, extensive pedigree analysis has become feasible. We therefore anticipated that determination of the origin of mutation could be achieved in a comparatively great number of families. Although these investigations often were restricted by the availability of blood samples from the maternal grandparents or great-grandparents, we were able to prove a de novo mutation in 9 of 20 families with sporadic hemophilia B and in 3 of 20 families with a history of the disease. This could be achieved with the aid of RFLP analysis and, in one case, where the mutation is still unknown, with the aid of biochemical and immunological factor IX assays. Since the maternal grandfather was decreased in two of these families, the germ line of origin could not be determined precisely. In the remaining families, the female and male germ lines turned out to be the origin of mutation in six and four cases, respectively, and an effect of paternal age on the mutations observed could not be excluded. Furthermore, our data indicate that the hemophilia B gene pool is mainly renewed by variable mutations.
通过基因组扩增和直接测序,我们在67名主要来自德国的非亲缘关系血友病B患者中确定了致病突变。随着该突变的检测,广泛的系谱分析变得可行。因此,我们预计在相当数量的家庭中可以确定突变的起源。尽管这些研究常常受到来自外祖父母或曾祖父母血液样本可用性的限制,但我们能够在20个散发性血友病B家庭中的9个以及20个有该病家族史的家庭中的3个中证实存在新发突变。这可以借助限制性片段长度多态性(RFLP)分析来实现,在一个突变仍未知的案例中,则借助生化和免疫因子IX检测来实现。由于其中两个家庭的外祖父已故,无法精确确定突变的起源种系。在其余家庭中,女性和男性种系分别在6例和4例中被证明是突变的起源,并且不能排除父亲年龄对所观察到的突变的影响。此外,我们的数据表明,血友病B基因库主要通过可变突变来更新。